12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-27), Neuronetics's 12-1 Month Momentum % is 113.45%.
The industry rank for Neuronetics's 12-1 Month Momentum % or its related term are showing as below:
STIM's 12-1 Month Momentum % is ranked better than 95.78% of 237
companies
in the Medical Diagnostics & Research industry
Industry Median: -18.51
vs STIM: 113.45
Competitive Comparison of Neuronetics's 12-1 Month Momentum %
For the Diagnostics & Research subindustry, Neuronetics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuronetics's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Neuronetics's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Neuronetics's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Neuronetics 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Neuronetics's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STIM has been successfully added to your